Price Alert: Omega Diagnostics outperforms over three months

Price Alert: Omega Diagnostics outperforms over three months

Article image

Shares in Omega Diagnostics (LON:ODX) have performed strongly against the market in recent weeks. On a 3-month relative price strength basis, the price is up by 5.22%. Its last close price was 56.5p.

This kind of outperformance can be driven by any number of factors, but there's no doubt that strong near term moves appeal to momentum traders in search of recoveries and breakouts. While market sentiment has generally been bullish in recent months, there are still big concerns about the earnings outlook for many companies in the months ahead. 

The upside for Omega Diagnostics is that investor optimism is translating into positive price momentum, which is regarded as a leading predictor of future performance...

Trading the trend

Research by some of the investment industry's most respected strategists shows that relative strength can be one of the most consistently useful pointers to growth.

Price momentum is heavily influenced by psychology, with investors under-reacting and subsequently over-reacting to company news, driving prices higher over time.

The catch is that investor sentiment is prone to wild swings, which makes momentum risky when used on its own. Combining it with other factors, like attractive valuation, high quality and low volatility, can help reduce that risk.

Overall, the upward trend in the share price of Omega Diagnostics over the past three months is a promising sign. But while the stock has been outperforming recently, relying on momentum in volatile markets can be hazardous.


What does this mean for potential investors?

Shares in Cambridge Nutritional Sciences have outperformed the market over the past three months - but momentum on its own is no guarantee of future returns.

To get a better idea about whether this trend will continue, it's worth doing some investigation yourself. Indeed, we've identified some areas of concern with Cambridge Nutritional Sciences that you can find out about here.

Alternatively, if you'd like to find more shares with strong price momentum, you can find them on this Outperforming the Market screen.


About us

Stockopedia helps individual investors make confident, profitable choices in the stock market. Our StockRank and factor investing toolbox unlocks institutional-quality insights into thousands of global stocks. Voted “Best Investment Research Tools” and “Best Research Service” at the 2021 UK Investor Magazine awards.

Cambridge Nutritional Sciences's StockRank™

Momentum TrapHighly Speculative

Cambridge Nutritional Sciences's StockRank™

With a StockRank of 46, Cambridge Nutritional Sciences is in the bottom 46% of the 7,586 stocks we cover in Europe, according to our proprietary ranking system.

See the full StockReport

Absolutely Perfect

"Trialed multiple other platforms - this is by far my favourite. Other platforms do not even have half the stuff that you can find on Stockopedia. Love it!"

As per our Terms of Use, Stockopedia is a financial news & data site, discussion forum and content aggregator. Our site should be used for educational & informational purposes only. We do not provide investment advice, recommendations or views as to whether an investment or strategy is suited to the investment needs of a specific individual. You should make your own decisions and seek independent professional advice before doing so. Remember: Shares can go down as well as up. Past performance is not a guide to future performance & investors may not get back the amount invested.